Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders

Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders

US Patent 5482940 · Granted Jan 9, 1996

Estimated economic value: $27,633,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoacylglycerol lipase modulators for use in autism spectrum disorders2025
5-hydroxytryptamine receptor 7 activity modulators and their method of use2025
(S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment2025
5-hydroxytryptamine receptor 7 activity modulators and their method of use2025
Monoacylglycerol lipase modulators for use in autism spectrum disorders2024
5-hydroxytryptamine receptor 7 activity modulators and their method of use2024
Functionalized N,N-dialkylamino phenyl ethers and their method of use2024
Functionalized N,N-dialkylamino phenyl ethers and their method of use2024
Aminothiazole compounds and methods using same2023
Aminothiazole compounds and methods using same2023
Compositions and methods for treatment of insulin resistance2023
Functionalized N,N-dialkylamino phenyl ethers and their method of use2022